45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
15,475
Insurances with rates
13
CPT / HCPCS codes
14,679
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9347 | Tremelimumab-actl Soln for IV Infusion 300 MG/15ML | $90,036 | $36,014 | $106 | $63,025 | 7 |
| J9228 | Ipilimumab Soln for IV Infusion 200 MG/40ML (5 MG/ML) | $78,810 | $31,524 | $138 | $55,167 | 8 |
| J9298 | Nivolumab-Relatlimab-rmbw 240-80 MG/20ML | $67,136 | $26,854 | $148 | $46,995 | 7 |
| J2507 | Pegloticase Inj 8 MG/ML (For IV Infusion) | $66,774 | $26,710 | $2,746 | $46,742 | 8 |
| J9359 | Loncastuximab Tesirine-lpyl For IV Soln 10 MG | $61,658 | $24,663 | $163 | $43,160 | 7 |
| J1303 | Ravulizumab-cwvz IV Soln 1100 MG/11ML (100 MG/ML) | $52,164 | $20,866 | $169 | $36,515 | 7 |
| J2350 | Ocrelizumab Soln For IV Infusion 300 MG/10ML | $44,975 | $17,990 | $44.56 | $31,483 | 8 |
| J9332 | Efgartigimod alfa-fcab IV Soln 400 MG/20ML | $44,098 | $17,639 | $24.11 | $30,869 | 7 |
| L8687 | GENERATOR,NEUROSTIMULATOR SPINAL INTELLIS #97715 | $41,476 | $16,590 | $12,938 | $37,328 | 22 |
| J9309 | Polatuzumab Vedotin-piiq For IV Solution 140 MG | $40,567 | $16,227 | $103 | $28,397 | 7 |
| J9321 | Epcoritamab-bysp Subcutaneous Soln 48 MG/0.8ML | $35,938 | $14,375 | $41.88 | $25,157 | 7 |
| J9334 | Efgartigimod alf-Hyaluronidase-qvfc Sol 180-2000 MG-UNIT/ML | $35,643 | $14,257 | $25.42 | $24,950 | 7 |
| J9999 | Vincristine Sulfate Liposome IV Susp 5 MG/31ML (0.16 MG/ML) | $34,162 | $13,665 | $23,913 | $23,913 | 2 |
| J9026 | Tarlatamab-dlle For IV Infusion 10 MG | $32,723 | $13,089 | $1,173 | $22,906 | 6 |
| J1628 | Guselkumab IV Soln 200 MG/20ML (10 MG/ML) | $31,781 | $12,713 | $56.98 | $22,247 | 7 |
| J1302 | Sutimlimab-jome IV Soln 1100 MG/22ML (50 MG/ML) | $29,275 | $11,710 | $14.15 | $20,492 | 7 |
| J9061 | Amivantamab-vmjw IV Soln 350 MG/7ML | $28,647 | $11,459 | $16.91 | $20,053 | 7 |
| J9217 | Leuprolide Acetate (6 Month) For Inj Kit 45 MG | $27,971 | $11,188 | $132 | $19,580 | 8 |
| L8679 | GENERATOR,NEUROSTIM NON SINGLE INTERSTIM II | $27,842 | $11,137 | $13,921 | $25,058 | 16 |
| J9042 | Brentuximab Vedotin For IV Soln 50 MG | $27,675 | $11,070 | $188 | $19,372 | 8 |
| E0783 | PUMP,INFUSION PROG 20ML SYNCHROMED II#8637-20 | $26,630 | $10,652 | $13,315 | $23,967 | 16 |
| J9272 | Dostarlimab-gxly IV Soln 500 MG/10ML (50 MG/ML) | $26,273 | $10,509 | $183 | $18,391 | 7 |
| J9382 | Zenocutuzumab-zbco IV Soln Pack 375 MG/18.75ML (750 MG Dose) | $25,935 | $10,374 | $24.68 | $18,155 | 7 |
| J9022 | Atezolizumab IV Soln 1200 MG/20ML | $25,315 | $10,126 | $68.51 | $17,721 | 8 |
| J9024 | Atezolizumab-Hyaluronidase-tqjs Inj 1875-30000 MG-UNIT/15ML | $25,315 | $10,126 | $23.69 | $17,721 | 7 |
| J9119 | Cemiplimab-rwlc IV Soln 350 MG/7ML (50 MG/ML) | $24,762 | $9,905 | $21.97 | $17,333 | 7 |
| J2329 | Ublituximab-xiiy Soln For IV Infusion 150 MG/6ML | $24,131 | $9,652 | $53.06 | $16,892 | 7 |
| J9153 | Daunorubicin-Cytarabine Liposome For IV Inj 44-100 MG | $23,992 | $9,597 | $192 | $16,794 | 7 |
| J2327 | Risankizumab-rzaa IV Soln 600 MG/10ML (60 MG/ML) | $23,236 | $9,294 | $11.21 | $16,265 | 7 |
| 36906 | PERC MECH THROMB PERPH SEG W/STENT PTA FLUORO RS&I | $23,113 | $9,245 | $487 | $19,646 | 9 |
| J9144 | Daratumumab-Hyaluronidase-fihj Inj 1800-30000 MG-Unit/15ML | $23,105 | $9,242 | $41.68 | $16,174 | 7 |
| J0870 | Imetelstat Sodium For IV Soln 188 MG | $22,753 | $9,101 | $42.77 | $15,927 | 7 |
| J9380 | Teclistamab-cqyv Subcutaneous Soln 153 MG/1.7ML (90 MG/ML) | $22,692 | $9,077 | $25.19 | $15,884 | 7 |
| J9203 | Gemtuzumab Ozogamicin For IV Soln 4.5 MG | $22,288 | $8,915 | $177 | $15,602 | 7 |
| J3263 | Toripalimab-tpzi IV Soln 240 MG/6ML (40 MG/ML) | $20,826 | $8,330 | $29.56 | $14,578 | 7 |
| J3380 | Vedolizumab For IV Solution 300 MG | $20,473 | $8,189 | $15.98 | $14,331 | 8 |
| J9316 | Pertuzumab-Trastuz-Hyaluron-zzxf Inj 60 MG-60 MG-2000 UNT/ML | $20,293 | $8,117 | $46.58 | $14,205 | 7 |
| J1930 | Lanreotide Acetate Extended Release Inj 120 MG/0.5ML | $20,017 | $8,007 | $25.54 | $14,012 | 8 |
| J9301 | Obinutuzumab Soln for IV Infusion 1000 MG/40ML (25 MG/ML) | $19,692 | $7,877 | $59.25 | $13,784 | 8 |
| J9223 | Lurbinectedin For IV Soln 4 MG | $19,349 | $7,740 | $155 | $13,544 | 7 |
| J3101 | Tenecteplase For IV Soln Kit 25 MG | $19,316 | $7,726 | $129 | $13,521 | 8 |
| J2323 | Natalizumab for IV Inj Conc 300 MG/15ML | $19,286 | $7,714 | $18 | $13,500 | 8 |
| J2997 | Alteplase For Inj 100 MG | $19,114 | $7,646 | $70.84 | $13,380 | 8 |
| J9043 | Cabazitaxel Inj 60 MG/1.5ML (For IV Infusion) | $18,767 | $7,507 | $170 | $13,137 | 8 |
| J9289 | Nivolumab-Hyaluronidase-nvhy Inj 600-10000 MG-UNIT/5ML | $18,492 | $7,397 | $20.52 | $12,944 | 7 |
| J9273 | Tisotumab Vedotin-tftv For IV Solution 40 MG | $17,372 | $6,949 | $142 | $12,160 | 7 |
| 36905 | PERC MECH THROMB PERPH SEG W/PTA IMAGE RS&I-TECH | $16,072 | $6,429 | $423 | $13,661 | 9 |
| J9307 | Pralatrexate IV Inj 20 MG/ML | $15,944 | $6,378 | $294 | $11,161 | 8 |
| J9063 | Mirvetuximab Soravtansine-gynx IV Soln 100 MG/20ML | $15,932 | $6,373 | $52.12 | $11,153 | 7 |
| J9306 | Pertuzumab Soln for IV Infusion 420 MG/14ML (30 MG/ML) | $15,878 | $6,351 | $12.77 | $11,115 | 8 |
Showing top 50 of 15,475 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.